Biotechgate enters collaboration with Nasdaq GlobeNewswire

biotechgate nasdaq

Biotechgate, owned by Venture Valuation has partnered with Nasdaq GlobeNewswire to distribute Nasdaq’s GlobeNewswire press releases on Biotechgate and all its related country portals.

Through the collaboration, Biotechgate will provide Nasdaq GlobeNewswire with an additional worldwide and focused publication channel. Biotechgate will publish the Biotech and life science related news on its website and make it available free of charge to all its users. In addition the GlobeNewswire press releases are made available step-by-step on the 30 country specific life sciences directories run by Biotechgate, such as the Swiss Life Sciences Database ( or the UK Biotech Database ( Where possible, press releases are linked to the specific company profiles which are available in the global Biotechgate database. Jost Renggli, COO of Venture Valuation / Biotechgate said:

This feed of news and press releases from GlobeNewswire adds great value to our global company directory. Users are able, not just to find new partners on our website, but also the latest news about the specific company.

The Biotechgate Database is property of Venture Valuation AG, headquartered in Switzerland with offices in Singapore, UK, Ireland and the US. Biotechgate is a directory with more than 38,000 company profiles, pipeline products and management details. Life sciences executives around the globe use Biotechgate to identify new business partners or licensing opportunities. All data in the database is updated on an ongoing basis.